Cover Image
市場調查報告書

北美的微生物培養市場預測

North America Microbiology Culture Market Outlook to 2024

出版商 GlobalData 商品編碼 347960
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
Back to Top
北美的微生物培養市場預測 North America Microbiology Culture Market Outlook to 2024
出版日期: 2017年12月01日 內容資訊: 英文 122 Pages
簡介

本報告提供北美的微生物培養市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 北美的微生物培養市場

  • 收益實際成果·預測
  • 類別比較:各收益
  • 收益實際成果
  • 收益預測
  • 企業佔有率:各收益

第4章 加拿大的微生物培養市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 墨西哥的微生物培養市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 美國的微生物培養市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 北美的微生物培養市場上主要企業概要

  • bioMerieux S.A.
  • Becton, Dickinson and Company
  • Siemens Healthcare
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Alere Inc.

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0751DB

GlobalData's new report, North America Microbiology Culture Market Outlook to 2024, provides key market data on the North America Microbiology Culture market. The report provides value, in millions of US dollars within market segments - Bacterial Identification & Susceptibility Testing, Blood Culture, Immunological Culture Identification, Microbiology Analyzers, Mycobacteria Culture, Mycology Culture and Parasitology Culture

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Microbiology Culture market segments - Bacterial Identification & Susceptibility Testing, Blood Culture, Immunological Culture Identification, Microbiology Analyzers, Mycobacteria Culture, Mycology Culture and Parasitology Culture
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Microbiology Culture market.
  • Key players covered include Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc and Thermo Fisher Scientific Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 What Is This Report About? 7
  • 2.2 Microbiology Culture Market Segmentation 7
  • 2.3 Definitions of Markets Covered in the Report 8

3 Microbiology Culture Market, North America 10

  • 3.1 Microbiology Culture Market, North America, Revenue ($m), 2010-2024 10
  • 3.2 Microbiology Culture Market, North America, Category Comparison by Revenue ($m), 2010-2024 12
  • 3.3 Microbiology Culture Market, North America, Revenue ($m), 2010-2017 14
  • 3.4 Microbiology Culture Market, North America, Revenue ($m), 2017-2024 16
  • 3.5 Microbiology Culture Market, North America, Company Share by Revenue ($m), 2017 18

4 Microbiology Culture Market, Canada 20

  • 4.1 Microbiology Culture Market, Canada, Revenue ($m), 2010-2017 20
  • 4.2 Microbiology Culture Market, Canada, Revenue ($m), 2017-2024 22
    • 4.2.1 Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), by Segment, 2010-2017 24
    • 4.2.2 Microbiology Analyzers Market, Canada, Revenue ($m), by Segment, 2010-2017 26
    • 4.2.3 Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), by Segment, 2017-2024 28
    • 4.2.4 Microbiology Analyzers Market, Canada, Revenue ($m), by Segment, 2017-2024 30
  • 4.3 Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), 2017 32
  • 4.4 Microbiology Culture Market, Canada, Company Share by Revenue ($m), 2017 33

5 Microbiology Culture Market, Mexico 35

  • 5.1 Microbiology Culture Market, Mexico, Revenue ($m), 2010-2017 35
  • 5.2 Microbiology Culture Market, Mexico, Revenue ($m), 2017-2024 37
    • 5.2.1 Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), by Segment, 2010-2017 39
    • 5.2.2 Microbiology Analyzers Market, Mexico, Revenue ($m), by Segment, 2010-2017 41
    • 5.2.3 Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), by Segment, 2017-2024 43
    • 5.2.4 Microbiology Analyzers Market, Mexico, Revenue ($m), by Segment, 2017-2024 45
  • 5.3 Microbiology Culture Market, Mexico, Distribution Share by Revenue ($m), 2017 47
  • 5.4 Microbiology Culture Market, Mexico, Company Share by Revenue ($m), 2017 48

6 Microbiology Culture Market, United States 50

  • 6.1 Microbiology Culture Market, United States, Revenue ($m), 2010-2017 50
  • 6.2 Microbiology Culture Market, United States, Revenue ($m), 2017-2024 52
    • 6.2.1 Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), by Segment, 2010-2017 54
    • 6.2.2 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2010-2017 56
    • 6.2.3 Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), by Segment, 2017-2024 58
    • 6.2.4 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2017-2024 60
  • 6.3 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2017 62
  • 6.4 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2017 63

7 Overview of Key Companies in North America Microbiology Culture Market 65

  • 7.1 bioMerieux SA 65
    • 7.1.1 Company Overview 65
  • 7.2 Becton Dickinson and Co 65
    • 7.2.1 Company Overview 65
  • 7.3 Thermo Fisher Scientific Inc 65
    • 7.3.1 Company Overview 65
  • 7.4 Beckman Coulter Inc 65
    • 7.4.1 Company Overview 65
  • 7.5 Bio-Rad Laboratories Inc 66
    • 7.5.1 Company Overview 66
  • 7.6 Himedia Laboratories Pvt Ltd 66
    • 7.6.1 Company Overview 66

8 Microbiology Culture Market Pipeline Products 67

9 Recent Developments 68

  • 9.1 Corporate Communications 68
    • 9.1.1 Sep 22, 2017: Neogen announces management change 68
    • 9.1.2 Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 68
    • 9.1.3 Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 69
    • 9.1.4 Jul 17, 2017: Neogen names new CEO 69
    • 9.1.5 May 17, 2017: Advanced Instruments Announces Appointment of Byron Selman as CEO 70
    • 9.1.6 Apr 11, 2017: Organovo Announces CEO Transition 70
    • 9.1.7 Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company's Two Primary Business Segments 71
    • 9.1.8 Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 72
    • 9.1.9 Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team 72
    • 9.1.10 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 72
    • 9.1.11 Dec 07, 2016: Neogen names chief science officer 73
  • 9.2 Financial Announcements 73
    • 9.2.1 Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results 73
    • 9.2.2 Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance 75
    • 9.2.3 Oct 25, 2017: Thermo Fisher Scientific Reports Third Quarter 2017 Results 76
    • 9.2.4 Oct 04, 2017: Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures to Improve Operational Efficiency 78
    • 9.2.5 Sep 19, 2017: Neogen reports 21% net income increase 79
    • 9.2.6 Aug 09, 2017: Organovo Announces Fiscal First-Quarter 2018 Results; Company Affirms Full-Year Fiscal 2018 Outlook 80
    • 9.2.7 Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 81
    • 9.2.8 Jul 26, 2017: Thermo Fisher Scientific Reports Second Quarter 2017 Results 83
    • 9.2.9 Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 84
    • 9.2.10 Jul 18, 2017: Neogen reports record revenues and earnings 85
    • 9.2.11 Jul 12, 2017: Premaitha Health: Investment Agreement Extension with Thermo Fisher Scientific 87
    • 9.2.12 Jun 07, 2017: Organovo Announces Fiscal Fourth-Quarter and Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook 87
    • 9.2.13 Jun 01, 2017: Announcement on submission of the Clinical Trial Plan Notification for phase I clinical trial of Oncolytic virus HF10 against pancreatic cancer in Japan 88
    • 9.2.14 Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 89
    • 9.2.15 Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 90
    • 9.2.16 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 92
    • 9.2.17 Mar 22, 2017: Verona Pharma Enters Global Strategic Clinical Development Services Agreement with QuintilesIMS for RPL554 93
    • 9.2.18 Mar 21, 2017: Neogen reports 24% increase in net income 95
    • 9.2.19 Mar 13, 2017: DJO Global Announces The Launch of The AltiVate Anatomic Shoulder System 96
    • 9.2.20 Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance 96
    • 9.2.21 Feb 09, 2017: Organovo Announces Fiscal Third-Quarter 2017 Results 98
    • 9.2.22 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 99
    • 9.2.23 Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 101
    • 9.2.24 Jan 18, 2017: Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA 102
    • 9.2.25 Jan 18, 2017: Teva Receives FDA Approval for VANTRELA ER (Hydrocodone Bitartrate) Extended-Release Tablets [CII] Formulated with Proprietary Abuse Deterrence Technology 104
    • 9.2.26 Jan 18, 2017: Dermata Therapeutics Announces Initiation of Treatment in a Phase 2 Acne Rosacea Clinical Study 105
    • 9.2.27 Jan 17, 2017: Encore Dermatology Announces Launch of Tridesilon (desonide) Cream, 0.05% 106
    • 9.2.28 Jan 16, 2017: ORYZON Announces Expansion of its Scientific Advisory Board 107
    • 9.2.29 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 108
    • 9.2.30 Dec 24, 2016: Genor Biopharma's PD-1 antibody Genolimzumab got clinical trial approval from the CFDA 108
    • 9.2.31 Dec 21, 2016: Notice Concerning the Phase I Clinical Study on NC-6004 for Patients with Head and Neck Cancer in Japan 109
    • 9.2.32 Dec 21, 2016: Neogen reports 23% increase in net income 110
  • 9.3 Legal And Regulatory 111
    • 9.3.1 Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 111
    • 9.3.2 Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 111
    • 9.3.3 Nov 29, 2016: C3 Jian announces names change to C3J Therapeutics 112
    • 9.3.4 Nov 29, 2016: C3 Jian Announces Corporate Name Change and Expansion of Management Team 112
  • 9.4 Other Significant Developments 112
    • 9.4.1 Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries 112
    • 9.4.2 Jul 18, 2017: BD Transforms Microbiology Urine Testing 113
    • 9.4.3 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 113
  • 9.5 Product News 114
    • 9.5.1 Apr 05, 2017: Pall Fortebio Launches the Octet Red96E System For More Versatile Biologics Characterization 114
  • 9.6 Strategy And Business Planning 114
    • 9.6.1 Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 114

10 Appendix 116

  • 10.1 Research Methodology 117
    • 10.1.1 Coverage 117
    • 10.1.2 Secondary Research 117
    • 10.1.3 Primary Research 118
    • 10.1.4 Market Modeling and Forecasting 119
    • 10.1.5 Company Share Analysis 120
    • 10.1.6 Distribution Share Analysis 121
    • 10.1.7 Benchmarking 121
  • 10.2 GlobalData Consulting 121
  • 10.3 Contact Us 122
  • 10.4 Disclaimer 122

List of Tables

1.1 List of Tables

  • Table 1: Microbiology Culture Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 11
  • Table 2: Microbiology Culture Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 13
  • Table 3: Microbiology Culture Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 15
  • Table 4: Microbiology Culture Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 17
  • Table 5: Microbiology Culture Market, North America, Company Share by Revenue ($m), USD Constant, 2017 19
  • Table 6: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 21
  • Table 7: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 23
  • Table 8: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 25
  • Table 9: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 27
  • Table 10: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 29
  • Table 11: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 31
  • Table 12: Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 32
  • Table 13: Microbiology Culture Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 34
  • Table 14: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 36
  • Table 15: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 38
  • Table 16: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 40
  • Table 17: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 42
  • Table 18: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 44
  • Table 19: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 46
  • Table 20: Microbiology Culture Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 47
  • Table 21: Microbiology Culture Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 49
  • Table 22: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 51
  • Table 23: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 53
  • Table 24: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 55
  • Table 25: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 57
  • Table 26: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 59
  • Table 27: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 61
  • Table 28: Microbiology Culture Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 62
  • Table 29: Microbiology Culture Market, United States, Company Share by Revenue ($m), USD Constant, 2017 64
  • Table 30: Microbiology Culture Market Pipeline Products 67
  • Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 119

List of Figures

1.2 List of Figures

  • Figure 1: Microbiology Culture Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 10
  • Figure 2: Microbiology Culture Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 12
  • Figure 3: Microbiology Culture Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 14
  • Figure 4: Microbiology Culture Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 16
  • Figure 5: Microbiology Culture Market, North America, Company Share (%) 2017 18
  • Figure 6: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 20
  • Figure 7: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 22
  • Figure 8: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 24
  • Figure 9: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 26
  • Figure 10: Bacterial Identification & Susceptibility Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 28
  • Figure 11: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 30
  • Figure 12: Microbiology Culture Market, Canada, Company Share (%) 2017 33
  • Figure 13: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 35
  • Figure 14: Microbiology Culture Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 37
  • Figure 15: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 39
  • Figure 16: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 41
  • Figure 17: Bacterial Identification & Susceptibility Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 43
  • Figure 18: Microbiology Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 45
  • Figure 19: Microbiology Culture Market, Mexico, Company Share (%) 2017 48
  • Figure 20: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 50
  • Figure 21: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 52
  • Figure 22: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 54
  • Figure 23: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 56
  • Figure 24: Bacterial Identification & Susceptibility Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 58
  • Figure 25: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 60
  • Figure 26: Microbiology Culture Market, United States, Company Share (%) 2017 63
Back to Top